Issn Print: 0098-7484
Publication Date: 2017/08/22
PCSK9 Inhibitors and the Choice Between Innovation, Efficiency, and Affordability
Daniel B. Mark; Kevin A. Schulman
Author Information: Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.